This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The University of Tokyo. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Naoaki Mizuno: Innovator in Chimeric Animal Research
Introduction
Naoaki Mizuno is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biomedical research, particularly in understanding the immune responses in chimeric animals. His work has opened new avenues for treating inflammation that occurs after birth in these unique organisms.
Latest Patents
Naoaki Mizuno holds a patent for his invention titled "Finding and treatment of inflammation after birth in chimeric animal." This groundbreaking patent reveals that chimeric animals experience noticeable inflammation after birth, a phenomenon that had not been previously reported. The invention provides a composition aimed at suppressing immune response or inflammation during the fetal period of a born chimeric animal, addressing a critical gap in existing research.
Career Highlights
Mizuno is affiliated with The University of Tokyo, where he conducts his research and develops innovative solutions to complex biological problems. His work is characterized by a commitment to advancing scientific knowledge and improving health outcomes for chimeric animals.
Collaborations
Throughout his career, Naoaki Mizuno has collaborated with esteemed colleagues such as Hiromitsu Nakauchi and Tomoyuki Yamaguchi. These partnerships have enriched his research and contributed to the success of his innovative projects.
Conclusion
Naoaki Mizuno's contributions to the field of chimeric animal research are invaluable. His patent addressing inflammation after birth demonstrates his commitment to advancing scientific understanding and improving health outcomes. His work continues to inspire future innovations in biomedical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
